Pharmaceutical manufacturers of Ginkgo biloba extract

Finzelberg is a top producer of active plant extracts and provider of complete product solutions. Since 1875, we have been a dependable, unwavering ally to the pharmaceutical and healthcare sectors globally, manufacturing top-quality active plant components. Through our range of patented and scientifically supported ingredients, we deliver efficient solutions with unique benefits.

The Martin Bauer Group is a prominent producer and provider of teas, essences, and plant-based products for the food, drink, dietary supplement, and phytopharmaceutical sectors. The Finzelberg business unit, which will be showcased, specializes in herbal extracts for phytopharmaceuticals and nutritional supplements

With a company history spanning over 150 years, Dr. Willmar Schwabe is one of the most traditional pharmaceutical family businesses in Europe. Due to the intensive and extensive research, our founder Dr. Willmar Schwabe is considered a pioneer of evidence-based phytotherapy. We invest more than 35 million euros annually in research and development and place great value on manufacturing in Germany. Despite the enormous growth since its founding, Schwabe has remained a family business to this day - with a focus on regionality and the needs of our customers.

Cara Partners operates as a bulk pharmaceutical manufacturer located in Little Island Industrial Estate within County Cork. This French-German joint venture, a collaboration between the Ipsen Group of France and the Schwabe Group of Germany, produces various standardised Ginkgo Biloba Extract Formulations, an active pharmaceutical ingredient (API). The joint venture selected Ireland as its production site due to its membership in the EU. Cara Partners specifically manufactures a standardised extract of Ginkgo Biloba, an Active Pharmaceutical Ingredient (API), at their facilities in Little Island within County Cork, Ireland.